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Abstract
Objective: To prevent surgical site infections, we conducted the Breakthrough 
Quality Improvement Project to optimize antimicrobial prophylaxis for 
abdominal hysterectomy. The specific aims were to increase the propor-
tion of patients who receive prophylactic antimicrobial therapy within 1 hour 
prior to incision and increase the proportion of patients whose prophy-
lactic antimicrobial therapy is discontinued within 24 hours after the end 
time of surgery.
Materials and Methods: The Breakthrough model was introduced by 
the Taiwan Joint Commission on Hospital Accreditation. It consisted of 
experts’ meetings, learning sections and action periods with Plan-Do-Study-
Act cycles. The control group included 43 patients undergoing abdominal 
hysterectomy and 29 patients were enrolled as the experimental group. 
Timing and duration of antimicrobial prophylaxis, incidence of surgical site 
infection, and hospital and antibiotic costs were recorded.
Results: The patients who followed the recommendations had no surgical 
site infections within 30 days after the end of surgery. Prophylaxis admin-
istration within 1 hour prior to incision was significantly increased from 
69.3% to 92.4%. Prophylaxis duration of less than 24 hours was significantly 
increased from 25% to 100%. The length of hospital stay, hospital costs 
and antibiotic costs were all reduced.
Conclusion: We successfully introduced the Breakthrough Project to 
improve the quality of medical care through antimicrobial prophylaxis. By 
applying this important management model, we were able to optimize the 
timing and duration of antimicrobial prophylaxis in patients undergoing 
abdominal hysterectomy. Our experience demonstrates that this is one 
of the choices for effectively dealing with quality of medical care issues. 
[Tzu Chi Med J 2008;20(2):112–118]
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1. Introduction
Surgical site infection accounts for a considerable 
proportion of all nosocomial infections. Apart from 
causing major morbidity and mortality, surgical infec-
tions increase hospital stays and therefore contrib-
ute to the cost of hospitalization [1–3]. In addition to 
improvements in operating room ventilation, steril-
ization methods, and barriers and surgical technique, 
antimicrobial prophylaxis is an important factor in re-
ducing infections. Increasing numbers of elderly sur-
gical patients who have underlying chronic, debilitating 
or immunocompromising diseases, and the emer-
gence of antimicrobial-resistant pathogens, have meant 
that effective antimicrobial prophylaxis cannot be 
overemphasized [4,5].
Many reports in the literature support the use of an-
tibiotic prophylaxis for various surgical procedures 
[6–19]. Timing and duration of antibiotic prophylaxis 
are important determinants for the effectiveness of 
the prophylaxis [20–23]. The National Surgical Infection 
Prevention Project of the United States published an-
timicrobial prophylaxis for surgery guidelines in 2005 
[24], which demonstrated that infusion of the first anti-
microbial dose should begin within 60 minutes prior to 
surgical incision and that prophylactic antimicrobial 
agents should be discontinued within 24 hours of the 
end of surgery. These consensuses were also included 
in the official documents of hospital accreditation and 
reimbursement in Taiwan. However, failure to follow the 
recommended guidelines of surgical antibiotic prophy-
laxis in daily clinical practice is not uncommon: either 
the wrong initiation time or prolonged antimicrobial 
duration because of physicians’ lack of knowledge or 
confidence can occur. Therefore, we joined the Break-
through Quality Improvement Project of the Taiwan 
Joint Commission on Hospital Accreditation (TJCHA) 
in 2006 to improve the antimicrobial prophylaxis of 
abdominal hysterectomies. The specific aims were: (1) 
to increase the proportion of patients having antimi-
crobial prophylaxis initiated within 1 hour prior to in-
cision; (2) to increase the proportion of patients whose 
antimicrobial prophylaxis is discontinued within 24 
hours after the end of surgery; (3) to evaluate the 
change in hospital stay costs and antimicrobial usage 
costs after application of the Breakthrough model.
2. Materials and methods
2.1. Duration, setting and population
We collected 15 months of data on associated meas-
ures from the data bank of the International Quality 
Indicator Project (IQIP) in the gynecological ward of 
a 1000-bed tertiary-care hospital in eastern Taiwan. 
There were 22 beds and four gynecological surgeons. 
The trends of each measurement before, during and 
after the 3-month Breakthrough Improvement Project 
were analyzed (Fig. 1). A total of 72 patients were en-
rolled. The baseline control group consisted of 43 pa-
tients undergoing abdominal hysterectomy before the 
initiation of the Breakthrough Project. The experimen-
tal group consisted of 29 patients enrolled prospec-
tively after the Breakthrough Project had begun. All 
patients were cared for according to the Institutional 
Declaration of Patients Rights and Obligations, which 
was modified from the principles of the Declaration of 
Helsinki on the treatment of human subjects. By clinical 
judgment, patients needing therapeutic antibiotics 
before surgery were excluded.
2.2. Breakthrough model
The Breakthrough Quality Improvement Project was 
conducted from September to November 2006. This 
model was developed by the Institute for Health Impro-
vement (IHI) in Massachusetts and consists of two parts. 
The first part includes three fundamental questions: 
(1) what are we trying to accomplish? (setting aims); (2) 
how will we know that a change is an improvement? 
(establishing measures); (3) what changes can we make 
that will result in improvement? (selecting changes). 
The second part is the Plan-Do-Study-Act (PDSA) cycles 
to test and implement changes in a real work setting. 
Three 1- to 2-day learning sections interspersed with 
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Fig. 1 — Scheme demonstrates the time frame of the Break-
through Quality Improvement Project on antimicrobial 
prophylaxis for abdominal hysterectomy. The experimental 
design consisted of an 8-month baseline control period, 
a 3-month Breakthrough Project period and a 4-month 
follow-up. The Breakthrough Project included 3 learning 
sections and 3 action periods. Many Plan-Do-Study-Action 
cycles were developed during the action periods to solve 
specific problems and work out processes that were con-
sidered in the learning sections. P = plan; D = do; S = study; 
A= action; LS = learning section; AP = action period.
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three 3- to 4-week action periods made up the main 
time frame of the Breakthrough series (Fig. 1). A nation-
wide experts’ meeting was held before the first learning 
section to establish a collaborative charter and change 
package.
2.3. Recommended antimicrobial 
prophylaxis [24]
It was recommended that cefazolin 1 g, intravenous in-
fusion 3–5 minutes, for patients with body weight 
< 80 kg (2 g if body weight > 80 kg) 30–40 minutes prior 
to incision be used. The same dose of cefazolin was 
administered every 3 hours before surgical wound clo-
sure. The antibiotic was discontinued before 24 hours 
after the initial dose and no oral antibiotic was pre-
scribed. For patients allergic to β-lactam, clindamycin 
or vancomycin was considered. However, the infusion 
time needs to be 10–60 minutes for clindamycin and 
> 60 minutes for vancomycin.
2.4. Measurements
The following measurements were recorded. Some of 
them are indicators of the Taiwan Quality Indicator 
Project (TQIP) [25]. Measurements are reported per 
100 of the denominator.
2.4.1. TQIP measures
1. 2b.7b antibiotic prophylaxis for abdominal hys-
terectomy within 1 hour prior to incision. Denom-
inator is the number of abdominal hysterectomy 
patients receiving antibiotic prophylaxis. Numerator 
is the number of abdominal hysterectomy patients 
receiving antibiotic prophylaxis within 1 hour of 
incision.
2. 2b.7d antibiotic prophylaxis for abdominal hys-
terectomy with a duration of < 24 hours. Denom-
inator is the number of abdominal hysterectomy 
patients receiving antibiotic prophylaxis. Numerator 
is the number of abdominal hysterectomy patients 
receiving antibiotic prophylaxis for a duration of 
< 24 hours.
3. 2a.11 surgical site infections for abdominal hys-
terectomy patients before discharge.
2.4.2. Non-TQIP measures
1. Surgical site infections of abdominal hysterectomy 
patients within 1 month after surgery.
2. Total inpatient hospital costs for abdominal hyster-
ectomy patients.
3. Cost of antibiotics for abdominal hysterectomy 
patients.
2.5. Statistical analysis
Data are expressed as values per 100 of the denom-
inator or mean ± standard error (mean ± SE). Student’s 
t test or Mann-Whitney rank sum test were used to ana-
lyze differential effects. A probability value of p< 0.05 
was considered to be indicative of a statistically 
significant difference.
3. Results
3.1. Prophylactic antibiotics for abdominal 
hysterectomy patients
The trends of timing and duration of prophylactic 
antibiotics for abdominal hysterectomy patients are 
demonstrated in Fig. 2. The incidence of patients 
with antibiotic duration < 24 hours reached 100% 2 
months before the Breakthrough Project. The timing 
of prophylactic antibiotic administration was gener-
ally limited to 30–60 minutes before incision after 
the Breakthrough Project. The incidence of cefazolin 
infusion initiated within 1 hour prior to incision was 
significantly elevated from 69.3 ± 8.73% to 92.4 ±
5.13% after the Break-through intervention (Fig. 3A). 
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Fig. 2 — Trends analysis of antimicrobial prophylaxis for 
abdominal hysterectomy shows that the duration of cefazo-
lin usage that was < 24 hours is 100% and the antimicrobial 
infusion was given 30–60 minutes prior to incision more 
frequently after the Breakthrough Project.
TZU CHI MED J  June 2008  Vol 20  No 2 115
The incidence of prophylactic duration was also signifi-
cantly increased from 25.0 ± 16.37% to 100.0 ± 0.00% 
(Fig. 3B). Both incidences showed that our hospital 
was approaching and exceeding the incidences of hos-
pitals that joined the IQIP in Taiwan and worldwide 
after the Breakthrough Project (Figs. 4 and 5).
3.2. Surgical site infection
One patient in the baseline control group developed 
a surgical site infection during her hospital stay. She 
had a National Nosocomial Infection Surveillance 
System (NNIS) Risk Index of 2 [26]. The infection sub-
sided after surgical drainage and the wound healed 
by secondary intention. No patient in the Breakthrough 
group developed surgical site infection during the in-
patient period. The inpatient infection rates for each 
group were 2.32% and 0.00%, respectively. However, 
a 52-year-old woman in the Breakthrough group with 
a body weight of 52 kg and a NNIS Risk Index of 0, was 
found to have an infected hematoma in the pelvis 2 
weeks after discharge. Tracing back to her perioper-
ative medical records, she had 1 g cefazolin infusion 
initiated 85 minutes after incision. The overall surgical 
time was 120 minutes. No postoperative antibiotic 
was given. She was discharged on the third day after 
hysterectomy.
3.3. Hospital stay and costs
A trend of reduced hospitalized duration from 
7.16 ± 0.72 to 5.86± 0.20 days was observed (Fig. 6A). 
The hospital and antimicrobial costs were normalized 
by means of the baseline control group. It was found 
that the normalized hospital costs were reduced to 
81.4± 3.32% and the normalized antibiotic costs to 
10.9± 0.36% (Figs. 6B and 6C).
4. Discussion
The Breakthrough Project on surgical antimicrobial 
prophylaxis effectively reduced hospital stay, hospital 
costs and antimicrobial costs for patients undergoing 
abdominal hysterectomy. Major concerns on antibiotic 
selection, dosage, timing, re-dosing and duration were 
all improved in clinical practice. A clinical path of a 
single preoperative dose of cefazolin without any post-
operative antibiotics produced 100% antibiotic prophy-
laxis for less than 24 hours before the study. However, 
the timing of giving cefazolin 30–60 minutes before 
incision was not followed until the initiation of the 
Breakthrough Project. The timings for antibiotic prophy-
laxis administration are not mutually exclusive: those 
cases treated within the first 30 minutes should also 
be included in the 1 hour and 2 hour results. The ideal 
situation is the trend of cefazolin within 30 minutes 
prior to incision (Fig. 2) approaching 0% and that of 
1 hour approaching 100%. Both indicators of prophy-
lactic timing (92.4% within 1 hour) (Fig. 3A) and pro-
phylactic duration (100% < 24 hours) (Fig. 3B) are above 
the average level of the world IQIP hospitals after the 
Breakthrough Project (Figs. 4 and 5). The incidence of 
surgical site infection during the inpatient period was 
0.00% in the Breakthrough group and 2.32% in the 
control group. Due to the small number of inpatient 
infections, it is difficult to stress statistical difference 
in the infection rate during the inpatient period. 
However, it was clear that there was no inpatient sur-
gical infection in the Breakthrough group. Only one 
case in the Breakthrough group developed infection 
and that occurred 2 weeks after discharge. Not surpris-
ingly, it was the patient who was not treated in 
adherence with the recommended prophylactic 
guidelines: cefazolin was given 85 minutes after inci-
sion because the first-line doctor in the emergency 
department forgot to prescribe prophylactic antibiotics. 
A meta-analysis of 2507 patients who underwent mesh 
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Fig. 3 — The Breakthrough Project for abdominal hysterectomy patients significantly increased: (A) the incidence of 
prophylactic antibiotics initiated within 1 hour prior to incision; (B) the incidence of prophylactic antibiotics for a duration
of < 24 hours. Control group, n= 43; Breakthrough group, n= 29. *p< 0.05, Student’s t test; †p< 0.05, Mann-Whitney rank 
sum test.
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inguinal hernioplasty showed that antibiotic prophy-
laxis decreased the rate of surgical site infection by 
almost 50% [27]. Our experience was compatible 
with the concept that antibiotics given after incision 
do not provide adequate protection from surgical site 
infection. The Mie Surgical Infection Research Group 
demonstrated that the incidence of surgical site infec-
tion in elective gastric cancer surgery was similar 
for both single-dose and multiple-dose antibiotic 
prophy laxis regimens [28]. It is clear that the timing 
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Fig. 4 — The trend of antimicrobial prophylaxis given 
within 1 hour prior to incision for abdominal hysterectomy 
patients in the target hospital was compared to those of 
the International Quality Indicator Project (IQIP) hospitals 
in Taiwan and worldwide. The trend gradually approached 
the level of IQIP hospitals and reached 100% after the 
Breakthrough Project.
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Fig. 5 — The trend of antimicrobial prophylaxis duration 
of < 24 hours for abdominal hysterectomy patients was 
compared to those of the International Quality Indicator 
Project (IQIP) hospitals in Taiwan and worldwide. The trend 
exceeded the level of IQIP hospitals and was 100% during 
and after the Breakthrough Project.
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of initiation is the key for antimicrobial prophylaxis 
and not the length of time the antibiotic is adminis-
tered. So we conducted this Breakthrough Project to 
consolidate this important concept and change the 
clinical behavior of surgeons.
The keys for successful improvement in the qual-
ity of medical care are the support of the administra-
tion system and the involvement of clinicians. We 
received direct support from the office of the super-
intendent and an efficient team was set up once the 
TJCHA had made the call. Members included a vice 
superintendent who acted as a team supervisor, a 
senior surgeon as team leader, a gynecological chief, 
an operating room head nurse, the chairman of an-
esthesiology, nursing practitioners, physicians of in-
fectious disease subspecialties and quality improvement 
staff. The leadership was established directly from 
the top and authorized by the chairman of the gyne-
cology department. Familiarity with the TQIP system 
also played a major role in facilitating implementa-
tion of the recommended antibiotic prophylaxis regi-
men. We had about 30 interdepartmental meetings 
every year to feedback and discuss quality of medi-
cal care indicators. Most of the physicians agreed 
that to improve the quality of medical care is one of 
the aims of our hospital. Practically, the team treated 
the clinicians as customers. We explained the impor-
tance of quality improvement in antibiotic prophy-
laxis. We let the first-line staff understand that this 
was not about criticism but a continuous improve-
ment in quality of care. Evidence-based literature and 
references were provided in the collaborative charter 
and change package from the TJCHA. Most surgeons 
were convinced, and changed their concepts and be-
havior after objective statistical data was made avail-
able. For example, orthopedic and cardiac surgeons 
started to reduce the antibiotic prophylactic duration 
to 24 hours for knee arthroplasty and coronary ar-
tery bypass surgery.
5. Conclusion
This Breakthrough Project brought the administra-
tion system of antimicrobial prophylaxis to the atten-
tion of surgeons and they then focused on this 
specific issue. We successfully increased the rate of 
antibiotic prophylaxis given within 1 hour prior to in-
cision, increased the rate of antibiotic prophylaxis du-
ration that is not longer than 24 hours, and reduced 
length of hospital stay, hospital costs and antibiotic 
costs. All the patients who followed the prophylactic 
antibiotic recommendations did not suffer surgical 
site infection within 30 days of surgery. A continuous 
effort to reinforce the concept of antimicrobial 
prophylaxis to all health workers is necessary to main-
tain and spread the gain.
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